Evonik Evonik

X

Find the latest Drugs in Development and Pipeline Prospector News of Megalith Pharmaceuticals.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Megalith Pharmaceuticals
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
302 Carnegie Center Suite 100 Princeton, NJ 08540
Telephone
Telephone
(609) 356 – 0210
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

The agreement covers exclusive commercialization rights to CRB-701, a novel clinical stage antibody drug conjugate (ADC) targeting Nectin-4, in the United States, Canada, the European Union (including the European Free Trade Area), the United Kingdom, and Australia.


Lead Product(s): Antibody-drug Conjugate

Therapeutic Area: Oncology Product Name: CRB-701

Highest Development Status: Phase IProduct Type: Large molecule

Partner/Sponsor/Collaborator: Corbus Pharmaceuticals

Deal Size: $692.5 million Upfront Cash: $7.5 million

Deal Type: Licensing Agreement February 13, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY